Volume 23, Issue 2 (February 2025)                   Int J Reprod BioMed. 2025, 23(2): 141-152 | Back to browse issues page

Ethics code: IR.SSU.RSI.REC.1403.004


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moeinaddini S, Dashti S, Amini Majomerd Z, Hatamizadeh N. Endometrial compaction can improve assisted reproductive technology outcomes in frozen-thawed embryo transfer cycles using hormone replacement therapy: A cross-sectional study. Int J Reprod BioMed. 2025; 23 (2) :141-152
URL: http://ijrm.ir/article-1-3499-en.html
1- Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran., Yazd Reproductive Sciences Institute, Bouali Ave., Safaeyeh, Yazd, Iran. Postal Code: 8916877391
2- Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. , saeideh_dashti@yahoo.com
Abstract:   (1705 Views)
Background: Endometrial compaction (EC) is an ultrasound evaluation method that may predict assisted reproductive technology outcomes.
Objective: This study aimed to assess the impact of EC on assisted reproductive technology outcomes in frozen embryo transfer cycles with hormone replacement therapy.
Materials and Methods: In this cross-sectional study, 100 women who underwent first or second frozen embryo transfer cycle at Yazd Reproductive Sciences Institute, Yazd, Iran from June to October 2024 were included. Endometrial thickness was compared between the day of starting progesterone and embryo transfer day. Then participants were divided into 2 groups, no compaction and compaction group. Biochemical, clinical, and ongoing pregnancy rates (OPR) were assessed between the 2 groups.
Results: Statistically significant differences were observed in biochemical, clinical, and OPR between the compaction and no compaction groups. Logistic regression analysis demonstrated significantly higher pregnancy rates in EC 10-15% and > 15%. We found a significant influence of EC 10-15% (p = 0.02, p = 0.01, p = 0.01), and EC > 15% (p = 0.002, p = 0.001, and p = 0.002) on biochemical, clinical, and OPR, respectively.
Conclusion: EC after progesterone administration in hormone replacement therapy-frozen embryo transfer cycles can increase biochemical, clinical, and OPR. The percentage of EC changes also influence the outcomes of these cycles.

Full-Text [PDF 427 kb]   (1153 Downloads) |   |   Full-Text (HTML)  (197 Views)  
Type of Study: Original Article | Subject: Fertility & Infertility
* Corresponding Author Address: Yazd Reproductive Sciences Institute, Bouali Ave., Safaeyeh, Yazd, Iran. Postal Code: 8916877391

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb